Frontiers corrects funding disclosure in goat IGF-1 oocyte study
Bottom line
A newly published correction in Frontiers in Veterinary Science doesn’t change the science behind a recent goat reproduction paper, but it does update the record on who funded the work. The correction applies to a June 2026 study from researchers at Universitas Airlangga that reported improved in vitro maturation of Capra hircus oocytes with insulin-like growth factor 1, or IGF-1. In the original study, adding IGF-1 at 100 ng/mL increased maturation rates versus control and was linked to higher PDE3A expression and kisspeptin levels, lower Gja4 and caspase-3 expression, and no significant change in IL-6 or caspase-9. The correction says funding acknowledgments were omitted and should have included the Indonesian Endowment Fund for Education and Universitas Airlangga. (frontiersin.org)
Why it matters: For veterinary professionals following assisted reproduction research, this is mainly a publication-integrity update, not a change in findings or methods. The underlying paper still points to a potentially useful IVM protocol refinement for caprine embryo production, an area where oocyte quality and standardized maturation systems remain limiting factors in small-ruminant IVEP. Reviews in the field have noted that improving oocyte competence is still one of the main bottlenecks to wider use of in vitro embryo production in goats and sheep. (frontiersin.org)
What to watch: Watch for whether the group, or others, validate the 100 ng/mL IGF-1 protocol in downstream embryo development and field-level reproductive programs, not just oocyte maturation endpoints. (frontiersin.org)
Key facts
- Journal
- Frontiers in Veterinary Science
- Article type
- Correction
- Study topic
- IGF-1 supplementation during in vitro maturation of Capra hircus oocytes
- Correction focus
- Omitted funding acknowledgments
- Funding added
- Indonesian Endowment Fund for Education and Universitas Airlangga
- Best-performing dose
- 100 ng/mL IGF-1
- Maturation rate
- 72.4% with 100 ng/mL, versus 50.6% in controls
- Culture time
- 22 hours
- Key molecular findings
- Higher PDE3A and kisspeptin, lower Gja4 and caspase-3, no significant change in IL-6 or caspase-9
A correction in Frontiers in Veterinary Science has updated the publication record for a recent caprine reproduction study on IGF-1 supplementation during in vitro maturation, but it doesn’t appear to alter the study’s data, conclusions, or proposed mechanism. Instead, the change addresses omitted funding acknowledgments tied to the Indonesian Endowment Fund for Education and Universitas Airlangga. (public-pages-files-2025.frontiersin.org)
The corrected paper builds on growing interest in improving in vitro embryo production in small ruminants, where lab-to-field efficiency still lags behind cattle. Recent reviews describe oocyte quality, seasonality, and inconsistent maturation protocols as persistent barriers to broader commercial and conservation use of IVEP in goats and sheep. That gives even narrowly focused IVM studies outsized relevance for breeding programs, germplasm preservation, and research herds. (animal-reproduction.org)
In the original study, cumulus-oocyte complexes from goats were cultured for 22 hours in maturation media containing 0, 50, 100, or 150 ng/mL IGF-1. The best-performing dose was 100 ng/mL, which raised maturation rates to 72.4%, compared with 50.6% in controls, while 150 ng/mL lost that benefit, suggesting a biphasic response. Molecular analyses then compared control oocytes with the 100 ng/mL group and found higher PDE3A expression and kisspeptin protein levels, alongside lower Gja4 and caspase-3 expression. IL-6 and caspase-9 were not significantly different. Correlation and path analyses in the paper pointed to PDE3A-linked meiotic resumption and reduced apoptosis as the main drivers of the improved maturation outcome. (frontiersin.org)
Mechanistically, the paper fits with broader reproductive biology literature. PDE3A is a key regulator of intra-oocyte cAMP and meiotic arrest, while gap-junction signaling and apoptosis control are central to oocyte competence during IVM. Related work in sheep and cattle has also linked IGF-1-associated signaling to better maturation or developmental potential, though species differences and lab conditions matter, and direct translation across systems is never automatic. (frontiersin.org)
There doesn’t appear to be substantial outside expert commentary yet on this specific correction, which is not unusual for a funding update. Industry reaction is also likely to be muted because the correction is administrative rather than scientific. Still, the original paper’s focus lands in an active area of small-ruminant reproductive research, where investigators are trying to move from improved maturation markers toward better embryo yield, cryotolerance, and practical herd-level outcomes. (animal-reproduction.org)
Why it matters: For veterinarians and reproduction specialists, the immediate takeaway is that this is a transparency correction, not a retraction, expression of concern, or methodological revision. The study’s core message remains intact: a defined IGF-1 dose may improve goat oocyte maturation in vitro through pathways tied to meiotic activation, gap-junction remodeling, and apoptosis suppression. That said, maturation rate is an upstream endpoint. In practice, veterinary reproductive programs care about whether these gains translate into better fertilization, blastocyst development, pregnancy rates, and usable embryo-transfer outcomes. (frontiersin.org)
The other reason this matters is editorial trust. Funding disclosures help readers assess context, potential conflicts, and the institutional support behind a study. Even when omitted unintentionally, those details are part of the scientific record. Corrections like this are routine, but they’re still important for clinicians, researchers, and industry readers who rely on journals to keep that record complete. (frontiersin.org)
What to watch: The next meaningful step is validation beyond maturation markers, especially studies testing whether the 100 ng/mL IGF-1 approach improves fertilization, embryo development, and transfer outcomes in goats, and whether the protocol holds up across breeds, seasons, and commercial lab settings. (frontiersin.org)